The company have substantially advanced this progress of an novel therapy for amyloid heart disease, utilizing the investigational drug. Initial trial results reveals promising improvements for patients diagnosed by the https://biotech295833.slypage.com/42689246/company-advances-cardiac-amyloidosis-management-with-the-drug